INSMED INC's ticker is and the CUSIP is 457669AA7. A total of 45 filers reported holding INSMED INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,972,933 | +284.6% | 2,000,000 | +300.0% | 0.00% | – |
| Q4 2021 | $513,000 | -93.8% | 500,000 | -93.8% | 0.00% | -100.0% |
| Q3 2021 | $8,288,000 | -58.0% | 8,000,000 | -54.8% | 0.00% | -60.0% |
| Q1 2021 | $19,753,000 | -52.9% | 17,686,000 | -52.4% | 0.01% | -54.5% |
| Q4 2020 | $41,947,000 | -24.1% | 37,186,000 | -26.6% | 0.01% | -31.2% |
| Q3 2020 | $55,295,000 | +37.6% | 50,686,000 | +23.1% | 0.02% | +14.3% |
| Q2 2020 | $40,199,000 | +422.9% | 41,186,000 | +356.7% | 0.01% | +366.7% |
| Q1 2020 | $7,688,000 | -34.0% | 9,019,000 | -25.0% | 0.00% | -40.0% |
| Q4 2019 | $11,645,000 | -34.8% | 12,019,000 | -43.6% | 0.01% | -37.5% |
| Q3 2019 | $17,854,000 | -14.0% | 21,319,000 | 0.0% | 0.01% | -20.0% |
| Q2 2019 | $20,772,000 | -37.3% | 21,319,000 | -35.0% | 0.01% | -37.5% |
| Q1 2019 | $33,117,000 | +59.3% | 32,819,000 | +11.9% | 0.02% | +45.5% |
| Q4 2018 | $20,793,000 | +718.0% | 29,319,000 | +877.3% | 0.01% | +1000.0% |
| Q3 2018 | $2,542,000 | +38.4% | 3,000,000 | +50.0% | 0.00% | 0.0% |
| Q2 2018 | $1,837,000 | -91.0% | 2,000,000 | -91.3% | 0.00% | -90.9% |
| Q1 2018 | $20,423,000 | – | 23,000,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Worth Venture Partners, LLC | 2,974,000 | $2,536,000 | 1.90% |
| Mohican Financial Management, LLC | 500,000 | $422,000 | 1.47% |
| LINDEN ADVISORS LP | 51,146,000 | $43,311,000 | 1.32% |
| ZAZOVE ASSOCIATES LLC | 15,101,000 | $12,810,000 | 1.11% |
| DLD Asset Management, LP | 24,500,000 | $20,911,000 | 1.03% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 31,749,000 | $26,863,000 | 0.55% |
| Cheyne Capital Management (UK) LLP | 1,000,000 | $853,000 | 0.51% |
| SSI INVESTMENT MANAGEMENT LLC | 6,000,000 | $5,050,000 | 0.39% |
| Jabre Capital Partners S.A. | 1,100,000 | $943,000 | 0.31% |
| Orbimed Advisors | 26,500,000 | $22,611,000 | 0.27% |